Semaglutide is the active ingredient in two brand-name injectable drugs approved by the Food and Drug Administration (FDA)
Clinical trials and post-marketing surveillance have not established a direct causal relationship between these medications and night sweats
While the parent trials primary outcomes were changes in adipose tissue volume (measured by CT) and body composition (DXA scans) at 32 weeks, our current analysis focuses on epigenetic aging markers as secondary/exploratory outcomes
A systematic review and meta-analysis published in BMC Gastroenterology found that constipation rates with GLP-1 receptor agonists were approximately 2.5 times higher than placebo groups
When decide to embark on this weight loss journey, Dr
Current PL inhibitors and their efficacy The rising global incidence of obesity is an urgent public health issue linked to numerous metabolic diseases, including type 2 diabetes, heart disease, and some cancers